Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-02-21
2000-05-09
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514320, 514337, 514345, A61K 3140, A61K 3144
Patent
active
060605030
ABSTRACT:
Certain benzopyran antiestrogens are disclosed for treating estrogen sensitive diseases such as breast cancer. Prodrug forms provide ease of manufacturing, good shelf life, and bioavailability, and preferred stereoisomers are shown to be more effective than racemic mixtures.
REFERENCES:
patent: 2875199 (1959-02-01), Cella
patent: 3321483 (1967-05-01), Crenshaw
patent: 3396169 (1968-08-01), Lednicer
patent: 3471520 (1969-10-01), Irmscher et al.
patent: 3597431 (1971-08-01), Coppola et al.
patent: 3995060 (1976-11-01), Neri et al.
patent: 4094994 (1979-06-01), Schonenberger et al.
patent: 4161540 (1979-07-01), Neri et al.
patent: 4213978 (1980-07-01), Bodor et al.
patent: 4368080 (1983-05-01), Crossley et al.
patent: 4472382 (1984-09-01), Labrie et al.
patent: 4659516 (1987-04-01), Bowler et al.
patent: 4659695 (1987-04-01), Labrie
patent: 4732912 (1988-03-01), Pilgrim et al.
patent: 4751240 (1988-06-01), Bowler et al.
patent: 4760061 (1988-07-01), Edwards et al.
patent: 4904661 (1990-02-01), Pilgrim et al.
patent: 4950684 (1990-08-01), Koszyk et al.
patent: 4963568 (1990-10-01), Schoenleber et al.
patent: 4975455 (1990-12-01), Brion et al.
patent: 5021432 (1991-06-01), Yamanaka et al.
patent: 5098903 (1992-03-01), Magarian et al.
patent: 5204337 (1993-04-01), Labrie et al.
patent: 5407947 (1995-04-01), Bryant et al.
Asselin, et al., J. Steroid Biochem. 9:1079-1081 (1978).
Auchus, et al., Biochemistry 25:7295-7300 (1986).
Bhatnagar, et al., J. Biol. Chem. 253:811-815 (1978).
Blickenstaff, et al., Steroids 46:889-902 (1985).
Bucourt, et al., J. Biol. Chem. 253:8221-8228 (1978).
Bundgaard, Textbook of Drug Design and Development, pp. 113-191 (1991).
CA:107--No. 154111(b):678, Oct. 1987--Alberola, et al.
CA:113(23)--No. 211775W:744, Dec. 1990--Sharma, et al.
CA:117(9)--No. 90146p:90147, Sep. 1992--Kapil, et al.
CA:86(1)--No. 5271Z:5280, Jan. 1977--Badran, et al.
Chin, et al., J. Biol. Chem. 255:3660-3664 (1980).
Chin, et al., J. Biol. Chem. 250:7682-7686 (1975).
Crenshaw, et al., J. Med. Chem. 14(2):1185-1190 (1971).
Dhar, et al., Contraception 44(4):461-472 (1991).
Druzgala, et al., J. Steroid Biochem. Mol. Bio. 38:149-54 (1991).
Durani, et al., J. Med. Chem. 32:1700-1707 (1989).
Friend, Critical Reviews in Therapeutic Drug Carrier Systems, 7(2):149-186 (1990).
Furr, et al., J. Endocr. 113:R7-R9 (1987).
Jones, et al., J. Med. Chem. 22(8):962-966 (1979).
Jordan, et al., Endocrinology 124:1717-1726 (1989).
Klijn, et al., J. Steroid Biochem. 420(6B):1381 (1984).
Mouridsen, et al., Cancer Treatment Rev. 5:131-141 (1978).
Poulin, et al., Cancer Res. 46:4933-4937 (1986).
Pruitt, et al., Organic Prep. & Proc. Int'l 22(2):235-244 (1990).
Saeed, et al., J. Med. Chem. 33:3210-3216 (1990).
Sharma, et al., J. Med. Chem. 33:3216-3229 (1990).
Sharma, et al., J. Med. Chem. 33(12):3222-3229 (1990).
Simard, et al., Mol Cell. Endo. 39:141-1444 (1985).
Simard, et al., Endocrinology 126:3223-3231 (1990).
Simard, et al., Mol. Cell. Endo. 2:775-784 (1988).
Stoessel, et al., J. Steroid Biochem. 25(5A):677-682 (1986).
Thomas, et al., J. Biol. Chem. 258:1587-1590 (1983).
Thomas, et al., J. Biol. Chem. 258:11500-11508 (1983).
Tobias, et al., J. Biol. Chem. 257:2783-2786 (1982).
von Angerer, et al., J. Med. Chem. 27:1439-1447 (1984).
Von Angerer, et al., J. Med. Chem. 33:2635-2640 (1990).
Wakeling, et al., J. Steroid Biochem. 30:141-147 (1988).
Wakeling, et al., Cancer Res. 51:3867-3873 (1991).
Wakeling, et al., J. Endo. 112:R7-R10 (1987).
Gauthier Sylvain
Labrie Fernand
Merand Yves
Criares Theodore J.
Endorecherche Inc.
LandOfFree
Benzopyran-containing compounds and method for their use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzopyran-containing compounds and method for their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzopyran-containing compounds and method for their use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1065595